重组人KIR2DL3(CD158b2)北京品牌

特别提示：包括重组人KIR2DL3(CD158b2)在内，本公司的所有产品仅可用于科研实验，严禁用于临床医疗及其他非科研用途！

产品名称：重组人KIR2DL3(CD158b2)
英文名称：Recombinant Human Killer Cell Immunoglobulin-like Receptor, Two Domain Long Cytoplasmic Tail, 3
产品货号：JN1554
产品规格：10μg|50μg|500μg|1mg

本品由我们的哺乳动物细胞表达系统制备而成，目的基因编码的His22-His245在C端带有Fc标签。

KIR2DL3/CD158b2 质量控制：＞95%(还原性SDS-PAGE)

KIR2DL3/CD158b2 制剂：冻干品

KIR2DL3/CD158b2 保存：
冻干蛋白置于-20℃以下可长期保存，室温条件下可稳定保存3周。
复溶蛋白溶液可在4～7℃保存2～7天，可分装后置于-20℃保存三个月。

KIR2DL3/CD158b2 复溶：
打开试剂管前请先离心。
复溶浓度推荐大于100 μg/ml。
冻干蛋白请溶于ddH2O。
复溶后，请根据用量分装冻存，避免反复冻融。

关于KIR2DL3/CD158b2 ：
Killer-Cell Immunoglobulin-Like Receptors (KIRs) are important cells of the immune system. KIRs are a family of Natural Killer (NK) Cells surface glycoproteins. KIRs control the killing function of these cells by interacting with MHC class I molecules. This interaction allows KIRs to identify virally infected cells or tumor cells by the distinctive low level of Class I MHC on their surface. The majority of KIRs are inhibitory, their recognition of MHC suppresses the cytotoxic activity of their NK cell. Only a limited number of KIRs have the capacity to activate cells. KIR2DL3 is an inhibitory Killer Cell Ig-like Receptor. KIR2DL3 recognizes class I MHC molecules (HLA-Cw1, -Cw3, -Cw7, and Cw8). KIR2DL3 inhibits the activity of NK cells thus preventing cell lysis.

我公司销售的重组人KIR2DL3(CD158b2)北京品牌，重组人Killer Cell Immunoglobulin-like Receptor, Two Domain Long Cytoplasmic Tail, 3，重组CD158b2，rhCD158b2，rCD158b2，重组人CD158b2，Recombinant Human Killer Cell Immunoglobulin-like Receptor, Two Domain Long Cytoplasmic Tail, 3，重组人KIR2DL3，rhKIR2DL3，重组Killer Cell Immunoglobulin-like Receptor, Two Domain Long Cytoplasmic Tail, 3，重组KIR2DL3，rKIR2DL3质量上佳，价格普惠，欢迎广大新老客户踊跃订购。